• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
  • First-line nivolumab plus cabozantinib outperforms sunitinib in advanced RCC patients

  • Modified FOLFIRINOX improves survival outcomes for patients with pancreatic cancer

  • Lifetime excess weight is associated with elevated risk of colorectal cancer

Recommended

Cancer trials

Sustained overall survival benefit with avelumab maintenance in advanced urothelial carcinoma

Clinical Practice

Lorlatinib: a new player in the evolving first-line treatment landscape for patients with ALK-...

Editor's pick

Relevant literature for your daily practice selected by: Dirk Schrijvers

subscribe Latest issue All issues Newsletters
Index latest issue
  • New oncology reimbursements in Belgium
  • Highlights in head and neck cancer
  • Highlights in genitourinary cancers
  • Highlights in gastrointestinal cancer
  • Highlights in lung cancer
  • Reflex testing for mutations in patients with early-stage non-small cell lung cancer: practical implications from ADAURA
  • Highlights in melanoma
  • Highlights in breast cancer
Pharma News

Tucatinib (Tukysa®) reimbursed as of October 2023

Health Innovation

Leuven-based tech company reports promising results with new imaging technology for low-grade ...

Science

Intra-arterial gemcitabine extends PFS in locally advanced pancreatic cancer

Cancer trials

Safety of neoadjuvant chemoradiotherapy followed by minimally invasive oesophagectomy

Want to know more about cancer prevention?

Subscribe

Also interesting

Covid-19

ASSOCIATIONS BETWEEN CLINICAL FACTORS AND RECENT ANTICANCER THERAPIES IN PATIENTS WITH CANCER ...

Health Innovation

Artificial Intelligence for Gleason grading of prostate cancer

ELCC 2022

Savolitinib in the treatment of patients with non-small cell lung cancer and MET exon 14 skipp...

Special

When angiogenesis meets immunology

Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023